⚗️Accent Microcell Ltd: A Micro Cap Company manufacturing Microcrystalline Cellulose
⚗️Company secured a purchase order for supplying 72,000 kgs of Cellulose Microcrystalline ACCEL-112
Detailed Company Analysis🧵👇
⚗️Company secured a purchase order for supplying 72,000 kgs of Cellulose Microcrystalline ACCEL-112
Detailed Company Analysis🧵👇
🔶Accent Microcell Ltd.:
🔹The company is a prominent manufacturer specializing in MCC (cellulose-based excipient) with more than ten years of industry expertise.
🔹The company is a prominent manufacturer specializing in MCC (cellulose-based excipient) with more than ten years of industry expertise.
🔹The company manufactures Microcrystalline Cellulose ("MCC"), an odorless, fine white powder derived from highly purified wood pulp.
🔶Key Metrics:
🔹M Cap: ₹585 Cr
🔹CMP: ₹278
🔹P/E Ratio: 45.0
🔹ROCE: 29.3%
🔹Debt to Equity: 0.08
🔹3 Years Sales Growth: 15.9%
🔹M Cap: ₹585 Cr
🔹CMP: ₹278
🔹P/E Ratio: 45.0
🔹ROCE: 29.3%
🔹Debt to Equity: 0.08
🔹3 Years Sales Growth: 15.9%
🔶Products and Brands:
The company offers seven products categorized under four brand names:
✍️Accel
🔹Microcrystalline Cellulose (MCC): The company manufactures 22 grades of MCC with particle sizes from 20 to 180 microns, serving diverse industries.
The company offers seven products categorized under four brand names:
✍️Accel
🔹Microcrystalline Cellulose (MCC): The company manufactures 22 grades of MCC with particle sizes from 20 to 180 microns, serving diverse industries.
🔹Microcrystalline Cellulose Spheres (MCC Spheres): MCC spheres serve as carriers for APIs and nutraceuticals in targeted drug delivery systems, ideal for capsules or tablets.
🔹Silicified Microcrystalline Cellulose (SMCC): SMCC is a co-processed blend of Microcrystalline Cellulose (MCC) and Colloidal Silicon Dioxide by spray drying technology.
🔹Powdered Cellulose (PC): Powdered Cellulose, also known as Alpha Cellulose, is a refined form derived from mechanically disintegrated alpha-cellulose found in fibrous plant materials.
✍️Acrocell:
🔹Croscarmellose Sodium (CCS):
CCS, a cross-linked polymer of Carboxy Methyl Cellulose and Sodium, white fibrous powder, aids tablet disintegration, enhances dissolution, and ensures optimal absorption.
🔹Croscarmellose Sodium (CCS):
CCS, a cross-linked polymer of Carboxy Methyl Cellulose and Sodium, white fibrous powder, aids tablet disintegration, enhances dissolution, and ensures optimal absorption.
✍️Maccel:
🔹Magnesium Stearate (MS): MS functions as a lubricant, ensuring smooth flow of the blend during manufacturing, primarily utilized in Pharmaceuticals & Nutraceuticals.
🔹Magnesium Stearate (MS): MS functions as a lubricant, ensuring smooth flow of the blend during manufacturing, primarily utilized in Pharmaceuticals & Nutraceuticals.
✍️Vincel:
🔹Microcrystalline Cellulose with Carboxy Methyl Cellulose (Co-Processed): MCC with Carboxy Methyl Cellulose offers diverse applications in Pharmaceuticals, Nutraceuticals, Food, Cosmetics, and Industrial sectors.
🔹Microcrystalline Cellulose with Carboxy Methyl Cellulose (Co-Processed): MCC with Carboxy Methyl Cellulose offers diverse applications in Pharmaceuticals, Nutraceuticals, Food, Cosmetics, and Industrial sectors.
🔶Manufacturing Facilities:
🔹The company has two manufacturing units in Pirana & Dahej, both in Gujarat.
✍️Unit 1: (Pirana)
🔹Installed Capacity: 6000
🔹Capacity Utilization: 95%
✍️Unit 2: (Dehaj)
🔹Installed Capacity: 2000
🔹Capacity Utilization: 100%
🔹The company has two manufacturing units in Pirana & Dahej, both in Gujarat.
✍️Unit 1: (Pirana)
🔹Installed Capacity: 6000
🔹Capacity Utilization: 95%
✍️Unit 2: (Dehaj)
🔹Installed Capacity: 2000
🔹Capacity Utilization: 100%
🔶Capex:
🔹The company plans to increase capacity by 2400 metric tonnes through ongoing capital expenditure.
🔹The company plans to increase capacity by 2400 metric tonnes through ongoing capital expenditure.
🔶International Presence:
🔹The company serves 45+ countries, including USA, Canada, Germany, Japan, China, Australia, Korea, Netherlands, Turkey, Vietnam, Italy, Indonesia, Poland, Egypt, France, Thailand, New Zealand, Brazil and others.
🔹The company serves 45+ countries, including USA, Canada, Germany, Japan, China, Australia, Korea, Netherlands, Turkey, Vietnam, Italy, Indonesia, Poland, Egypt, France, Thailand, New Zealand, Brazil and others.
🔶User Industries:
🔹The products of the company serve as texturizers, anticaking agents, binders, lubricants, bulking agents, and diluents, with applications in Pharmaceutical, Nutraceutical, Food, Cosmetic, and various other industries.
🔹The products of the company serve as texturizers, anticaking agents, binders, lubricants, bulking agents, and diluents, with applications in Pharmaceutical, Nutraceutical, Food, Cosmetic, and various other industries.
🔶Revenue Mix: (June, 2023)
✍️Segment Wise:
🔹Pharma: 72.74%
🔹Nutraceutical: 10.52%
🔹Food: 16.73%
✍️Geography Wise:
🔹Domestic: 38.42%
🔹International: 61.58%
Source: DRHP
✍️Segment Wise:
🔹Pharma: 72.74%
🔹Nutraceutical: 10.52%
🔹Food: 16.73%
✍️Geography Wise:
🔹Domestic: 38.42%
🔹International: 61.58%
Source: DRHP
🔶H1FY24 Financial Highlights:
🔹Revenue from Operations at ₹109 Cr.
🔹Operating Profit at ₹20 Cr
🔹OPM: 18% Vs 9% for FY23
🔹PAT at ₹14 Cr
🔹Basic EPS at ₹9.13
🔹Revenue from Operations at ₹109 Cr.
🔹Operating Profit at ₹20 Cr
🔹OPM: 18% Vs 9% for FY23
🔹PAT at ₹14 Cr
🔹Basic EPS at ₹9.13
🔶Key Highlights:
🔹The company is almost debt-free
🔹Both plants are currently operating at peak capacity in accordance with their order books.
🔹The company is currently working on a trial order received from a global leader in the pharmaceutical and chemical industry.
🔹The company is almost debt-free
🔹Both plants are currently operating at peak capacity in accordance with their order books.
🔹The company is currently working on a trial order received from a global leader in the pharmaceutical and chemical industry.
🔹OPM at 18.43% driven by lower input and freight costs.
🔶Order:
🔹Company secured purchase order from renowned M/s. N. G. P Tobacco ApS, Denmark for Cellulose Microcrystalline ACCEL-112.
🔶Order:
🔹Company secured purchase order from renowned M/s. N. G. P Tobacco ApS, Denmark for Cellulose Microcrystalline ACCEL-112.
🔶Industry Overview:
🔹India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications.
🔹Market size of India pharmaceuticals industry is expected to reach US$ 65 billion by 2024, and ~US$ 130 billion by 2030.
🔹India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications.
🔹Market size of India pharmaceuticals industry is expected to reach US$ 65 billion by 2024, and ~US$ 130 billion by 2030.
🔹The Microcrystalline Cellulose market is projected to reach $712.9 million by 2031, with a CAGR of 5.9% (2022-2031).
🔹Global population growth, rising disposable incomes, and consumer preference for packaged food are driving the microcrystalline cellulose market.
🔹Global population growth, rising disposable incomes, and consumer preference for packaged food are driving the microcrystalline cellulose market.
🔶Future Outlook:
🔹The company is establishing a new plant in Navagam Kheda for producing CCS, Sodium Starch Glycolate, and CMC.
🔹The company is establishing a new plant in Navagam Kheda for producing CCS, Sodium Starch Glycolate, and CMC.
🔹The company plans to allocate ₹33.6 Cr from IPO proceeds for machinery purchase. Production expected by March 2025.
🔹Focusing on optimizing product mix to boost revenue and margins for the upcoming year.
🔹Focusing on optimizing product mix to boost revenue and margins for the upcoming year.
⚡️Disclaimer: The above data should not be considered as a Buy or Sell recommendation. The analysis has been done for educational and learning purpose only.
✅Follow <@raghavwadhwa> for more insights on Micro cap companies and various sectors.
✅Join our Free telegram Channel t.me
✅Like & Retweet♻️
✅Visit our website samarwealth.com
✅Join our Free telegram Channel t.me
✅Like & Retweet♻️
✅Visit our website samarwealth.com
Loading suggestions...